CYRX — Cryoport, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1124524 ·
Last close
$19.74
Market Cap
$999.81M
52W High
$21.78
52W Low
$7.61
ADV30
1,092,797
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 50,220,000 23,834,000 -8,804,000 -10,852,000 750,945,000 279,179,000 267,431,000
Jun 2026 48,971,000 22,824,000 -10,039,000 -8,255,000 756,204,000 269,267,000 265,505,000
Mar 2026 47,798,000 21,913,000 -9,614,000 -10,544,000 763,609,000 272,912,000 268,620,000
Dec 2025 45,450,000 21,711,000 -10,031,000 -11,644,000 764,989,000 250,494,000 262,351,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$7,973,000
Investing CF
$27,267,000
Financing CF
$-4,283,000
CapEx
$-29,321,000
Dividends Paid
—
Buybacks
$-5,752,000
EPS Diluted TTM
$-0.90
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-707,683,000
Inventory
$21,506,000
Receivables
$36,454,000
ST Investments
$127,426,000
EBIT TTM
$-28,890,000
Pretax Income TTM
$-31,000,000
Interest Exp TTM
$2,110,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$192,439,008
EBITDA
$-4,629,000
Free Cash Flow
$-14,678,000
Enterprise Value
$805,926,144
Total Cash
$393,076,000
Total Debt
$231,511,008
Shares Out
50,649,100
Trailing EPS
$-0.90
Book Value
$9.54
ROE
-7.4%
ROA
-2.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 176,177,000 -36,806,000 78,301,000 764,989,000 262,351,000 502,638,000 -8,580,000
Dec 2024 156,769,000 -57,862,000 -114,756,000 703,492,000 301,594,000 401,898,000 -16,323,000
Dec 2023 168,662,000 -50,968,000 -99,587,000 957,744,000 468,721,000 489,023,000 -757,000
Dec 2022 237,277,000 -31,904,000 -37,333,000 1,038,746,000 482,908,000 555,838,000 -1,851,000

TTM Snapshot

Revenues TTM
$186,452,000
NetIncome TTM
$-33,697,000
OpCashFlow TTM
—
Assets (Latest)
$756,204,000
Forward EPS
$-0.66

Max Pain — expiry 2026-12-18

max pain strike: $17.50 · spot: $20.17 · call oi: 9,665 · put oi: 1,128
Expected Move to 2026-12-18: ±$2.56 (12.69%) — implied range $17.61 – $22.73 · ATM straddle on $20.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ANRO Alto Neuroscience, Inc. $999.16M $24.91 —
OMER OMEROS CORP $1.01B $13.92 —
SVRA Savara Inc $988.39M $4.48 —
MTRI InMed Pharmaceuticals Inc. $1.02B $17.50 —
JBIO Jade Biosciences, Inc. $979.40M $15.40 —

News headlines (Yahoo Finance, 1h cache)

Cryoport (CYRX) Stock Looks Fully Priced Following Its 129% Rebound
2026-11-13 15:14 · Yahoo
Why Cryoport (CYRX) Shares Climbed After Its Latest Update?
2026-11-10 21:14 · Yahoo
What Comes Next For Cryoport After A 100% Gain
2026-11-09 20:06 · Yahoo
Cryoport, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Cryoport (CYRX) Q3 2026 Earnings Call Transcript
2026-11-06 08:14 · Yahoo
CryoPort Inc (CYRX) (Q3 2026) Earnings Call Highlights: Record Clinical Pipeline and Positive ...
2026-11-06 05:23 · Yahoo
CryoPort Q3 Earnings Call Highlights
2026-11-06 05:14 · Yahoo
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
2026-11-05 21:45 · Yahoo
Cryoport Reports Third Quarter 2026 Financial Results
2026-11-05 21:05 · Yahoo
Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026
2026-10-22 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.